Figure 7
From: ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma
Impact of the ATS signature on T cells. (A) Marker gene distribution in exhausted CD4+ T cells and CD8+ T cells, respectively. (B) Correlation analysis of the ATS and the activity of exhausted CD4+ T cells or CD8+ T cells. (C) The distribution of ATS in different cell types using single-cell resolution. (D,E) ATS-related DEGs co-expression network and enrichment analysis in CD4+ and CD8+ T cells, respectively.
